The Center for Devices and Radiological Health (CDRH) branch of the FDA has granted 510(k) clearance for compatibility of the...
Mallinckrodt Plc announced the publication of findings from a retrospective chart review study assessing the real-world use and outcomes of INOmax (nitric oxide) gas, for inhalation therapy in hospitalized patients with COVID-19 and mild-to-moderate acute respiratory distress syndrome (ARDS), a disorder in which fluid leaks into the lungs, making breathing difficult or impossible.
Mallinckrodt plc, a leading specialty biopharmaceutical company, announced that it has completed its acquisition of Ikaria, Inc. at a purchase...
Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced that they have...